DGAP-News: Newron veröffentlicht Ergebnisse für da

DGAP-News: Newron veröffentlicht Ergebnisse für das erste Halbjahr 2022 und informiert zu aktuellen F&E- und Geschäftsaktivitäten

DGAP-News: Newron Pharmaceuticals S.p.A. / Schlagwort(e): Halbjahresbericht Newron veröffentlicht Ergebnisse für das erste Halbjahr 2022 und informiert zu aktuellen F&E- und Geschäftsaktivitäten 15.09.2022 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwo...

Related Keywords

Germany , Australia , Milan , Lombardia , Italy , United States , Taipei , T Ai Pei , Taiwan , Canada , South Korea , Switzerland , Italian , America , Onewron , Development Activities , Number Of Centers , Treatment Centers , Or Research Projects , Development Partnerships , S Distribution Services , Development Or Marketing Of Products , Italian Tax Credits For Research , Development Programs , Development Her , Management Team , Half Year , Business Activities , Interim Report Newron , Nervous System , Highlights John , Important Data , Promising Between Results , Active Ingredient , Half Of The Year , Patent Rights , Parkinsons Patients , Between Results , New Chemical Substance , Study Progress , Inter Alia , Newron Between Results , Secondary Goal , Latin America , Coming Europe , Total Number , Patient Recruitment , Included Success , More Mechanism , New Drug , Coming Reference , Newron Patent Rights , Reporting Period , January Director , Board Of Directors , Annual Report Start , Financial Ratios , Coming In Thousands , Revenue Interests Forschungs , Net Profit , June Via , December Liquid Middle , Financial Instruments , Total Assets , Newron Interim Report , With View , Royalty Income , Italian Tax Credits , Newron Ceo , Above Newron , Combined Arabic Emirates , Parkinsons Disease , Further Information , Switzerland Valentine , Important Notes This Document , Her Business Segments , Product Candidate , Marketing Her Product Candidate , Personnel Costs , Due Her Natural , High Bills , Future Events , Development Or Marketing , Side Effects , Market Launch , Come About , License Agreements , Developments Or Changes , Intentions Or Expectations , Combined States , Securities May , Financial Object , Reporting Obligations , Press Releases , Media Archive , Pharmaceuticals , S Pa , Schlagworte , Halbjahresbericht , Ergebnisse , Albjahr , F Ampe , Eschäftsaktivitäten , Et Cest , ür , Nhalt , Itteilung , Mittent , Herausgeber ,

© 2025 Vimarsana